Cargando…

A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

BACKGROUND: Over 500,000 women worldwide are diagnosed with ovarian or endometrial cancer each year. We have used a two-step strategy to identify plasma proteins that could be used to improve the diagnosis of women with an indication of gynecologic tumor and in population screening. METHODS: In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enroth, Stefan, Berggrund, Malin, Lycke, Maria, Lundberg, Martin, Assarsson, Erika, Olovsson, Matts, Stålberg, Karin, Sundfeldt, Karin, Gyllensten, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271635/ https://www.ncbi.nlm.nih.gov/pubmed/30519148 http://dx.doi.org/10.1186/s12014-018-9216-y

Ejemplares similares

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2019)

Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™
por: Berggrund, Malin, et al.
Publicado: (2016)

Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome
por: Gyllensten, Ulf, et al.
Publicado: (2020)

HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia
por: Berggrund, Malin, et al.
Publicado: (2019)

Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment
por: Enroth, Stefan, et al.
Publicado: (2022)

Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+
por: Berggrund, Malin, et al.
Publicado: (2020)

Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology
por: Gustavsson, Inger, et al.
Publicado: (2018)

Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases
por: Enroth, Stefan, et al.
Publicado: (2018)

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer
por: Gyllensten, Ulf, et al.
Publicado: (2022)

Diagnostic excision of the cervix in women over 40 years with human papilloma virus persistency and normal cytology
por: Aarnio, Riina, et al.
Publicado: (2019)

Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study
por: Aarnio, Riina, et al.
Publicado: (2020)

Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers
por: Lycke, Maria, et al.
Publicado: (2020)

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
por: Gustavsson, Inger, et al.
Publicado: (2019)

Clinical factors associated with quality of life among women with endometriosis: a cross-sectional study
por: Pontoppidan, Karin, et al.
Publicado: (2023)

Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines—a survey in Sweden
por: Halldorsdottir, Sandra, et al.
Publicado: (2018)

Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
por: Enroth, Stefan, et al.
Publicado: (2014)

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
por: Partheen, Karolina, et al.
Publicado: (2011)

Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing
por: Lindström, Annika Kristina, et al.
Publicado: (2018)

Effects of Long-Term Storage Time and Original Sampling Month on Biobank Plasma Protein Concentrations
por: Enroth, Stefan, et al.
Publicado: (2016)

Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women
por: Hermansson, Ruth S., et al.
Publicado: (2022)

Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers
por: Mukherjee, Shuvolina, et al.
Publicado: (2021)

Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
por: Kristjansdottir, Björg, et al.
Publicado: (2013)

External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
por: Partheen, Karolina, et al.
Publicado: (2009)

Protein profiling reveals consequences of lifestyle choices on predicted biological aging
por: Enroth, Stefan, et al.
Publicado: (2015)

ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer
por: Stålberg, Karin, et al.
Publicado: (2020)

Continuous Aging of the Human DNA Methylome Throughout the Human Lifespan
por: Johansson, Åsa, et al.
Publicado: (2013)

Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
por: Kristjansdottir, Björg, et al.
Publicado: (2012)

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer
por: Weiland, Florian, et al.
Publicado: (2020)

Validation of (18)F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study
por: Jónsdóttir, Björg, et al.
Publicado: (2021)

Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff
por: Sundkvist, Anneli, et al.
Publicado: (2018)

CanvasDB: a local database infrastructure for analysis of targeted- and whole genome re-sequencing projects
por: Ameur, Adam, et al.
Publicado: (2014)

TGF-β isoforms induce EMT independent migration of ovarian cancer cells
por: Gao, Jingfang, et al.
Publicado: (2014)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
por: Gutiérrez, Ariadna Lara, et al.
Publicado: (2021)

Psychometric evaluation of the Swedish version of the 30-item endometriosis health profile (EHP-30)
por: Grundström, Hanna, et al.
Publicado: (2020)

Demographic and clinical characteristics determining patient-centeredness in endometriosis care
por: Grundström, Hanna, et al.
Publicado: (2022)

Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health Study
por: Enroth, Stefan, et al.
Publicado: (2013)

The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases
por: Ahsan, Muhammad, et al.
Publicado: (2017)

Ovarian epithelial cancer: a role for PGE(2)-synthesis and signalling in malignant transformation and progression
por: Rask, Katarina, et al.
Publicado: (2006)

Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer
por: Liljedahl, Leena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_24evfc84b0506e5n52sulnef5f